CRISPR leg­end Jen­nifer Doud­na helps some re­cent col­lege grads launch a di­ag­nos­tics up­start

A group of re­cent and cur­rent grad stu­dents in the Bay Area have come to­geth­er to launch a new com­pa­ny that promis­es to use CRISPR tech­nol­o­gy to cre­ate a line­up of di­ag­nos­tic tests that may one day make di­ag­nos­ing can­cer or malar­ia or most any­thing a snap.

And aside from the tech they’ve in-li­censed out of Berke­ley, the young en­tre­pre­neurs have one big as­set in their fa­vor. Jen­nifer Doud­na, one of the most fa­mous sci­en­tif­ic pi­o­neers be­hind CRISPR/Cas9 gene edit­ing tech, is com­ing on board as a co-founder.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN